@IGCIRi
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States Android App
Account-level information from X, not a live location or the device used for a specific post.
NYSE American: IGC | Advancing Alzheimer's research through therapeutic innovation and AI https://nitter.cf/t.co/LWbCcXy5Ub
Maryland, US.
Joined October 2013
- Tweets2.6K
- Following205
- Followers1.1K
- Likes178
Sleep is essential for overall brain health, and researchers continue to explore how changes in sleep may be connected to Alzheimer's disease
What has research revealed so far?
Read more: igcpharma.com/how-sleep-supp…
#AlzheimersResearch #SleepResearch #BrainHealth
With target enrollment complete, IGC Pharma’s Phase 2 CALMA Alzheimer’s trial has officially transitioned from recruitment to the final stage ahead of topline results
Topline results are expected in Q4 2026
Read more: igcpharma.com/igc-pharma-com…
#AlzheimersResearch #IGCPharma
More than 55 million people worldwide are living with Alzheimer's disease
This World Alzheimer's Day, we recognize everyone affected by the disease and reaffirm our commitment to advancing Alzheimer's research
#WorldAlzheimersDay
Blood biomarkers are becoming an important area of Alzheimer's research
The most widely studied include:
• p-tau
• Amyloid-beta (Aβ)
• Neurofilament light (NfL)
Each provides researchers with different insights into the biology of Alzheimer's disease
#AlzheimersResearch
Women represent a disproportionate share of people living with Alzheimer's disease
Researchers continue to investigate how factors such as longevity, hormonal changes, genetics, and brain biology may contribute to this disparity
#AlzheimersDisease #WomensHealth
Advancing Alzheimer's research requires more than a single area of expertise
By bringing together diverse scientific disciplines, researchers can deepen our understanding of the disease and help drive future discoveries
#AlzheimersResearch #Neuroscience
MYTH vs. FACT: Alzheimer's Disease
There's a lot of misinformation about Alzheimer's disease. Let's separate fact from fiction with evidence-based insights
🧵↓
#AlzheimersDisease #BrainHealth
Myth 3: Nothing can be done after an Alzheimer's diagnosis.
Fact: While there is no cure, an early diagnosis can help people access treatment options, supportive care, and resources that may improve quality of life.
Source: National Institute on Aging (NIA)
Reliable information helps individuals, families, and caregivers make informed decisions about brain health.
Learn more through trusted organizations like the Alzheimer's Association and the National Institute on Aging.
#AlzheimersDisease
Alzheimer's disease is a global challenge, but its impact is not experienced equally around the world
Research across diverse populations is helping deepen our understanding of the factors that influence disease outcomes
Read more: igcpharma.com/alzheimers-acr…
#AlzheimersDisease
As CALMA approaches enrollment closure and expected Q4 topline readout, IGC Pharma is strengthening its regulatory readiness in preparation for potential engagement with the FDA and EMA
Read more: finance.yahoo.com/healthcare…
#AlzheimersResearch #ClinicalTrials #IGCPharma
@IGCPharma is 8 patients away from completing enrollment in its Phase 2 CALMA #Alzheimer’s trial.
The Company is strengthening its regulatory, biostatistical, AI-enabled data science, and strategic pharmaceutical development capabilities as IGC-AD1 advances toward expected Phase 2 topline results in the fourth quarter of 2026.
Read more: igcpharma.com/igc-pharma-str…
Changes in memory are among the most recognized symptoms of Alzheimer's disease, but they're not the only ones
Understanding the full range of symptoms can help foster greater awareness of the disease and its impact on patients and caregivers
#AlzheimersResearch #BrainHealth
Following the federal jury verdict in United States v. Andrew Left, IGC Pharma announced that it is evaluating potential civil remedies.
Read more: finance.yahoo.com/healthcare…
#NYSEAmerican #IGCPharma
Why is Alzheimer's disease so difficult to treat?
One reason is that Alzheimer's isn't driven by a single biological process. It involves multiple changes in the brain that scientists are still working to understand ↓
#AlzheimersResearch #Neuroscience
Because Alzheimer's involves multiple biological processes, researchers are exploring different therapeutic strategies
No single approach addresses every aspect of the disease, making continued research essential